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Abstract 
Circular dichroism spectroscopy has been used to study how different solvents stabilize secondary structure in the neuropeptide 
galanin (rat), two N-terminal fragments of galanin, galanin(l- 12) and galanin(1-16), and six other differently charged analogs. Among 
these analogs, the peptide M40, galanin(l-13)-Pro-Pro-Ala-Leu-Ala-Leu-Ala amide, is a high affinity, receptor subtype specific galanin 
receptor antagonist. The different solvents include sodium dodecyl sulfate (SDS) micelle solutions, 1,2-dioleoyl-sn-glycero-3-phospho- 
choline (DOPC) and 1,2-dioleoyl-sn-glycero-3-phosphoglycerol (DOPG) vesicle solutions, 100% 1,1,1,3,3,3-hexafluoro-2-propanol 
(HFP) and 100% 2,2,2-tfifluoroethanol (TFE). DOPC vesicles did not change the structure of the peptides as compared to aqueous 
solvent. The negatively charged DOPG vesicles and SDS micelles induced similar changes towards a-helical structures in all peptides. 
The HFP and TFE solvents have an even stronger tendency to stabilize a-helical conformations in these peptides. Since DOPG vesicles 
can be considered as a model system for negatively charged biological membranes, the solution structures observed in the presence of 
DOPG or SDS may be the most relevant for the in vivo situation. Correlations between the binding affinity of the peptides to 
hippocampal galanin receptors and their observed structures in the DOPG solvent were investigated. 
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1. Introduction 
Galanin [1] is a 29 amino acid long peptide (30 in 
humans [2]) which has several important functions in the 
neuro-endocrine system [3,4]. It is a potent inhibitor of 
insulin release [5] and it has the ability to stimulate the 
release of growth hormone [6]. Galanin also acts as an 
inhibitor of the release of acetylcholine in hippocampus 
[7]. Furthermore, the peptide is believed to have a tonic 
role in the control of pain threshold, especially after an 
injury of the peripheral nervous system [8]. It also has the 
ability to stimulate feeding behavior upon hypothalamic 
injection [9]. These and other biological functions of 
galanin are mediated via an identified membrane-bound 
high-affinity receptor. The receptor is a 54 kDa glyco- 
* Corresponding author. E-mail: astrid@biophys.su.se. Fax: +46 8 
155597. 
0005-2736/95/$09.50 © 1995 Elsevier Science B.V. All rights reserved 
SSDI 0005-2736(95)00056-9 
protein which is coupled to a pertussis toxin-sensitive 
G-protein I10]. 
It has been shown that the N-terminus of galanin is 
most important for binding to the receptor and that the 
most crucial residue is the tryptophan in position two 
[11,12]. The first 15 residues are also absolutely conserved 
in all species (cow, pig, rat, sheep, chicken, dog and 
humans) where the amino acid sequences have been deter- 
mined. Even a short fragment, galanin(1-12), has a good 
agonist activity in rat ventral hippocampus [13]. Lately, a 
number of putative chimeric galanin receptor antagonists 
have been designed (for review see [4]). These chimeric 
peptides contain the N-terminal part of galanin, galanin(1- 
13), and in the C-terminus a sequence belonging to another 
neuropeptide (bradykinin, substance P, spantide, neuropep- 
tide Y) or a non-specific sequence like Pro-Pro-Ala-Leu- 
Ala-Leu-Ala as in peptide M40. One of these antagonists, 
M40, which has been shown to block galanin-induced 
feeding [14,15], is studied in present paper. 
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To understand the action of galanin and its analogs at a 
molecular level, the knowledge of the three-dimensional 
structures involved is important. The solution structure of 
galanin has been determined in 100% 2,2,2-trifluoro- 
ethanol (TFE) [16]. In this solvent, galanin attains a struc- 
ture consisting of two a-helices interrupted by a bend at 
the only proline residue in position 13. By using circular 
dichroism spectroscopy we have investigated the sec- 
ondary structure of rat galanin, two fragments of galanin, 
galanin(1-12) and galanin(1-16), and six analogs to 
galanin in water, 100% HFP, 100% TFE or while interact- 
ing with phospholipid vesicles or detergent micelles. From 
the results and the characteristics of the peptide sequences 
and the solvents, some conclusions are drawn about the 
nature of the interactions between the peptides and the 
solvents. An attempt to correlate these results to biological 
function is also made by investigating the binding affinity 
of the peptides to hippocampal galanin receptors. 
2. Materials and methods 
2.1. Materials 
Sodium dodecylsulfate (SDS) was purchased from BDH 
Limited Poole, UK, 2,2,2-trifluoroethanol (TFE) and 
sodium chloride (NaC1) from E. Merck, Darmstadt, Ger- 
many, and l,l,l,3,3,3-hexafluoro-2-propanol (HFP)from 
Sigma, St. Louis, USA. 1,2-dioleoyl-sn-glycero-3- 
phosphocholine (DOPC) and 1,2-dioleoyl-sn-glycero-3- 
phosphoglycerol (DOPG) was purchased from Avanti Po- 
lar Lipids, USA. 
All peptides were synthesized as previously described 
[17]. Their sequences are summarized in Table 1. 
2.2. Sample preparation 
Stock solutions of 5.0 mg/ml of DOPC and DOPG 
unilamellar lipid vesicles were produced by sonication as 
previously described [18]. The sonicator used was a 
Soniprep 150 (MSE, Scientific Instruments, UK) supple- 
mented with an exponential microtip. The diameter of the 
DOPC- and DOPG-vesicles has been determined to be 
approx. 200 A [19]. 
Peptide solutions with a concentration of approx. 25 
p.M have been titrated with SDS and vesicle solutions, 
prepared from DOPC and DOPG respectively. In the titra- 
tion with SDS a 10 mM phosphate buffer (pH 7.0) was 
used, in all other cases pure water was used. The pH of 
these samples was varying between 4.4 to 5. The induced 
conformational changes were monitored by CD-spec- 
troscopy. Spectra of the peptides were recorded in solvents 
with 0, 1, 2, 5, 10 and 20 mM SDS and with 0, 0.025, 
0.05, 0.1, 0.2, 0.5, 1.0 and 2.0 mg/ml of vesicle solution, 
as well as in 100% HFP and 100% TFE. Several peptides 
were also studied in a 10 mM phosphate buffer solution 
(pH 7) with various concentrations of NaC1 (0-150 mM) 
and SDS (0-10 mM), as well as in a 0.1 mg/ml (0.13 
mM) DOPG solvent with various concentrations of NaCI 
(0-150 raM). 
2.3. Spectroscopic methods 
In order to determine the concentration f the peptides, 
absorbance spectra were acquired on a Beckman DU-7 
spectrophotometer or on a Cary 4 spectrophotometer. All 
peptides studied here have one tryptophan as the main 
contributor to absorbance in the 280 nm region. The 
concentration determination a d the quantitative evaluation 
of the CD spectra re dependent on the extinction coeffi- 
cient of the peptide. For all peptides, except galanin, the 
extinction coefficient was estimated from the sum of the 
molar absorbances of the aromatic residues involved [20]. 
The extinction coefficient for galanin dissolved in water 
has previously been determined to e278 = 6620 M-1 cm-J 
[21], in agreement to what can be estimated from the 
aromatic amino acid residues. 
CD-spectra were recorded at a temperature of 25 ° C, 
using a Jasco-720 spectropolarimeter and 2 mm Hellma 
quartz cuvettes. The parameters used were a bandwidth of 
Table 1 
Amino  acid sequences of  rat galanin, galanin fragments and analogs studied in this paper 
Galanin ,  rat 
Galanin(1-12) 
Galanin(1-16) 
M40 
M132 
M133 
M135 
M141 
M148 
5 10 15 20 25 29 
WT L N S A G Y L L G P H A I D N H R S F S D K H G L T -NH 2 
1 
G 
GWTL NS A G YL  L G 
GWT L NS  A GYL  L GP  HA1 
GWT L N S A GYL  L GP  P P AL  AL  A 
GWT L NS  A GYL  L GP  P PAL  AL  Y 
GWT L NS  A GYL  L GP  P P AKAL  Y 
GWT L NS  A GYL  L GP  P P AKAL  A 
G WT L N S A G Y L L G P P P A 
G WT L N S A G Y L L G P P P E L E L E 
1 5 10 15 20 
-NH 2 
-NH 2 
-NH 2 
-NH 2 
-NH 2 
-NH 2 
-NH 2 
-NH 2 
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1 nm, a 2 s response time, a resolution of 0.5 nm and a 
scan speed of 10 nm/min. The acquired spectra were the 
average of three continuous cans, usually measured be- 
tween 185 and 250 nm, and corrected with respect to 
baseline and for dilution. The spectra are presented in a 
noise reduced fashion. Using the assumption that only 
random coil and a-helical secondary structures were pre- 
sent, the mean residue ellipticity at 222 nm was evaluated 
and used as a measure of the relative helicity. At this 
wavelength the major contribution to a measured CD-sig- 
nal of a protein can be attributed to a typical random coil 
or an a-helical structure, with an ellipticity of 3900 and 
-38  000 deg- cm2/dmol, respectively [22,23]. 
2.4. Binding studies 
Binding studies to galanin receptors were carried out in 
rat ventral hippocampal membranes. Preparation of 
[125I]monoiodo-Tyr26-porcine galanin, preparation of the 
membranes and the displacement of 125I-porcine galanin 
by the studied ligands are described in detail in a previous 
report [24]. 
3. Results 
The sequences of rat galanin, its fragments and analogs 
are presented in Table 1. These peptides were dissolved in 
different solvents and studied by CD spectroscopy. The 
relative a-helical content of the peptides under varying 
solvent conditions was evaluated from the mean residue 
ellipticity at 222 nm, and the data are summarized in Table 
2. 
Table 2 
Estimated amount of a-helix in 
different solvents 
percent of the various peptides in the 
H 20 DOPC DOPG SDS HFP TFE 
Galanin, rat 14 13 17 16 22 41 
Galanin(l-12) 9 9 19 14 12 19 
Galanin(1-16) 11 12 22 14 17 21 
M40 11 ll 12 14 13 16 
MI32 11 11 17 14 20 19 
M133 10 10 15 14 20 28 
M135 10 l0 16 15 18 26 
M141 9 9 15 12 20 19 
M148 12 13 15 15 18 18 
This evaluation is dependent on the extinction coefficient for the peptides. 
It has previously been determined for galanin [21], but are estimated for 
all other peptides as the sum of the molar absorbance of the aromatic 
amino acids involved. Quantitative comparisons between the peptides 
should therefore be done with some caution. The uncertainty is approx. 
_+ 10% of the estimated percentage of a-helix, determined from repeated 
measurements. 
3.1. Solvent dependent s ructure stabilization 
As an example of how the peptides interact with the 
different solvents, the CD spectra of galanin dissolved in 
water, 0.1 mg/ml  DOPC, 0.1 mg/ml  DOPG, 10 mM 
SDS/10 mM phosphate buffer, 100% HFP and 100% TFE 
are shown in Fig. 1. The concentration of DOPG vesicles 
was chosen so that addition of more vesicle solution did 
not alter the conformation according to the CD spectra. 
The peptide/DOPG ratio corresponds to 1:5. In most cases 
the conformational change occurs already at the lowest 
concentration of DOPG, at a peptide/DOPG concentration 
ratio corresponding to 1:1. To ensure that we are above the 
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Fig. 1. CD spectra of rat galanin, dissolved in (1) water (--) ,  (2) 0.1 mg/ml DOPC (- - -), (3) 0.1 mg/ml DOPG ( . . . . .  ), (4) 10 mM SDS/10 mM 
phosphate buffer ( -  - -), (5) 100% HFP ( . . .  ) and (6) 100% TFE ( - -  - -  - -) ,  at a temperature of 25 ° C. 
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critical micellar concentration (CMC, at 8.2 mM [25]), we 
have used 10 mM SDS in the presented CD spectra, which 
corresponds to a peptide/SDS ratio of 1:400. It should 
however be noted that the same conformational change is 
induced by SDS well below the CMC (already at 1-2 mM, 
equivalent to a molar ratio of 1:40). 
A number of observations, related to the nature of the 
solvent, can be derived from Fig. 1 and Table 2. It is 
obvious that galanin does not interact with zwitterionic 
DOPC-vesicles. This observation holds for all studied 
peptides. 
Another observation on galanin as well as all the other 
peptides is that negatively charged DOPG vesicles and 
negatively charged SDS micelles both stabilize similar 
conformational changes. Addition of salt, up to 150 mM 
NaC1, to the DOPG samples induces conformational 
changes in the peptides towards a more random coil 
structure, whereas the peptides in the SDS solvent are 
unaffected by similar concentrations of NaC1 (data not 
shown). 
The fluorinated alcohols (HFP and TFE) have a some- 
what different effect on the peptides. In most cases they 
induce a larger amount of a-helix than the other solvents. 
TFE has the strongest tendency to induce a-helix, which is 
particularly apparent in the case of galanin, but also seen 
in the cases of M133 and M135 (Table 2, Fig. 2). 
We further observed that all the investigated peptides 
had identical CD spectra in 10 mM phosphate buffer (pH 
7.0) and pure water (pH measured as 4.4-5). 
3.2. Sequence-dependent structure stabilization 
Additional more specific observations, connected to the 
specific amino acid sequence, were also made. 
Table 3 
Equilibrium binding affinities of galanin and its analogs as determined by 
displacement of 0.1-0.2 nM 125I-galanin(1-29), porcine, in rat ventral 
hippocampal galanin receptors, taken from a [10], b [13] 
Peptide K D [nM] 
Galanin, rat 1.0 + 0.1 a 
Galanin(1-12) ~ 1400 _+ 100 h 
Galanin(l-16) c 3.1 + 0.7 b 
M40d 11.7+ 0.4 
M132 2.8+ 0.3 
M133 3.8+ 0.4 
M135 43.7+ 0.4 
M141 9.6+ 0.2 
M148 6.3_+ 0.1 
c Galanin agonist. 
d Galanin antagonist. 
Ko is the concentration of peptide that causes 50% of 125I-galanin(l-29) 
to be displaced from the receptor. 
The number of charged residues in the peptides eems 
to be of importance for the interaction with TFE (and to 
some extent HFP). This is seen in the spectra of Fig. 2, 
where the spectrum of M40 is compared with that of M 135 
as well as M132 to M133. In both pairs the only difference 
in the amino acid sequence is that the non-charged hy- 
drophobic residue, L-Leu tS, close to the carboxy terminal 
end, is exchanged to a hydrophilic positively charged 
L-Lys, with a side-chain of similar size. The exchange 
results in a clear increase of a-helical content of the 
peptides. Only minor differences in the CD-spectra and 
hence the secondary structure are seen in the other sol- 
vents. Introducing negatively charged amino acids in the 
C-terminal part, as in M148, does not give any significant 
differences relative to M40 and M132 (Table 2). 
The stabilization effect caused by a single hydrophobic 
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Fig. 2. CD spectra of M40 ( - - ) ,  M 132 (- - -), M 133 ( . . . . .  ) and M 135 ( -  - - )  dissolved in 100% TFE, at a temperature of 25 ° C. 
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aromatic residue was studied by comparing the peptides 
M40 and M132, as well as M135 and M133, where the 
L-AIa at position 20 is substituted to a L-Tyr. This substitu- 
tion causes a certain increase of secondary structure of the 
peptides in the fluorinated alcohols only (Fig. 2, Table 2). 
3.3. Binding studies 
The displacement of 125I-galanin from rat ventral hip- 
pocampal membranes by the peptides M40, M132, M133, 
M135, M141 and M148 was monitored and the binding 
affinities are summarized in Table 3, together with previ- 
ously known constants. 
4. Discussion 
Since the action of galanin and its analogs is mediated 
via a membrane bound specific receptor, the structures that 
these peptides attain close to or in contact with membranes 
should be those which are recognized by the receptor. A 
phospholipid vesicle is a spherical bilayer which can be 
considered as a model for a biomembrane and could 
therefore serve as a reasonable model system for studies of 
the interaction between a peptide and a biomembrane. 
Since biological membranes are negatively charged, a 
possible correlation between the structure of peptides in 
the DOPG solvent with their binding affinity to galanin 
receptors has been investigated. From the studies in the 
SDS, HFP and TFE solvents, it is possible to draw some 
conclusions about the mechanisms behind solvent induced 
conformational changes in the peptides. 
4.1. Electrostatic interactions 
The observation that negatively charged vesicles 
(DOPG), but not electrically neutral ones (DOPC), induce 
conformational changes of the peptides and that solutions 
of negatively charged SDS-micelles tabilize similar sec- 
ondary structures, indicates that the electrostatic forces are 
important to induce interactions between the peptides and 
the solvent molecules. FT-IR spectroscopy studies on 
porcine galanin and galanin analogs also support these 
observations [21]. It should be pointed out that the struc- 
tural changes in most cases appear at the lowest concentra- 
tion of DOPG and SDS. SDS actually induces these 
changes well below the CMC, acting probably as a 
monomer. Similar effects of anionic phospholipids on the 
secondary structures of peptides have previously been 
observed [19,21,26]. Addition of salt up to 150 mM NaC1 
should reduce the electrostatic nteraction and hence asso- 
ciation between the peptide and the SDS or DOPG 
molecules, resulting in a reduced stabilization and a less 
ordered peptide structure. This behavior is indeed observed 
in the DOPG solvent but not in the SDS solvent. The latter 
did, however, have a higher concentration of the am- 
phiphilic component, 10 mM SDS versus 0.1 mg/ml  (0.13 
raM) DOPG. 
With the peptides investigated here, the effects of intro- 
ducing single electrically charged hydrophilic residues on 
the secondary structure could also be studied. Peptides 
with a positively charged lysine (M133, M135) instead of 
neutral eucine close to the carboxy terminal (M40, M 132). 
dissolved in TFE, have a tendency to adopt a better 
defined a-helical conformation (Fig. 2). On the other 
hand, substitutions to negatively charged amino acids in 
the C-terminus, as in the peptide M148, do not lead to any 
structural change. Hence, the sign of the charged residue, 
as well as the position in the sequence, are not surpris- 
ingly, important factors. The observations above may be 
explained by the helix-dipole model, which predicts that 
helix formation is favored if the pole of the helix dipole 
and nearby charged residue are of opposite signs [27,28]. 
In accordance with the NMR-structure of galanin in TFE 
[16], it is reasonable to believe that the N-terminal part of 
the peptide has a tendency to form an a-helix. The C- 
terminal portion of this helix dipole has a negative sign 
and a positively charged residue close by (such as lysine) 
should therefore increase the a-helical content, as ob- 
served. 
4.2. Fluorinated alcohols as solvents 
The largest structural changes, compared to the aqueous 
solution, are observed in the fluorinated alcohols (HFP and 
TFE) and particularly in TFE. Several studies on solvent 
induced effects by these fluorinated alcohols have been 
performed previously, resulting in a number of possible 
proposed explanations. It has for instance been attributed 
to a change in the intramolecular hydrogen bond stability, 
caused by the solvent molecules difference in acidity and 
basicity [29,30], as well as size [31]. The physical proper- 
ties of these fluorinated alcohols also alters the electro- 
static interactions [30,32,33]. However, the observed struc- 
ture stabilization of the peptides caused by HFP and TFE 
as well as the differences between HFP and TFE, could not 
be explained by one single mechanism, but probably re- 
quires a combination of several mechanisms. 
4.3. Seconda~ structure uersus binding affinity 
From a biological point of view the peptide structure in 
the DOPG-solvent is most relevant in the comparison with 
the receptor affinities. 
The two galanin fragments and M I41 are rather similar 
in sequence (Table 1). A comparison between their struc- 
tures in the DOPG solvent shows that MI41 has the lowest 
tendency to form an a-helical conformation (Table 2), 
probably due to its proline tail, but still has a reasonable 
good binding affinity (Table 3). Furthermore, the shorter 
galanin fragment, galanin(1-12), attains almost as much 
a-helical conformation as galanin(l-16) but binds poorly 
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to the receptor. These observations suggest that the peptide 
must have a certain length as well as composition in the 
C-terminus to be efficiently bound by the receptors. 
The introduction of a hydrophobic residue in the pep- 
tides M132 and M133 leads to an increase of their binding 
ability (Table 3). This is correlated with an increased 
a-helical content only in the TFE solvent (Fig. 2), but not, 
e.g., in the DOPG solvent (Table 2). 
One of the studied peptides, M40, has been shown to 
function as an efficient antagonist to galanin, and is there- 
fore of special interest. The CD-spectra from both galanin 
and M40 in DOPG-vesicle as well as SDS-micelle solu- 
tions suggest that a significant fraction of the peptide 
bonds are in a disordered state (random coil). However, 
the spectra show that galanin has a somewhat larger 
amount of a-helical secondary structure than M40. This is 
possibly due to the fact that the C-terminal end of M40 is 
too short to attain a well defined secondary structure. The 
identical N-terminal part (13 amino acids) of galanin and 
M40, which is most important for receptor interaction, 
probably attains similar secondary structures in the pep- 
tides. 
4.4. Concluding remarks 
All peptides investigated in this study show stabilized 
secondary structures while interacting with negatively 
charged DOPG vesicles or SDS micelles. Since the 
DOPG-vesicle solvent system should be considered as a 
reasonable model system mimicking a membrane nviron- 
ment, the SDS-micelle system should be so as well. An 
even more accentuated stabilization effect is seen in the 
fluorinated alcohols. A general interpretation of the results 
is that the electrostatic nteractions and possible shielding 
from water interaction leads to a stabilized secondary 
structure of the peptides. 
The affinity of a peptide for a phospholipid membrane 
may be related to its biological activity, and may serve as a 
prerequisite for receptor interactions. We found no clear 
correlation between extent of stabilized structure of the 
peptides and their receptor affinities, which shows that 
receptor recognition as expected is governed by more 
specific forces between receptor and ligand. However, the 
observed interactions between peptide and negatively 
charged membranes suggests a mechanism for accumula- 
tion of the peptide at the membrane, which should bring 
the peptide into the vicinity of the receptor. This may be 
an important phenomenon governing the probability of 
peptide-receptor interactions. 
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